A carer records a short video of the subject’s face using a smartphone and answers questions about their behavior, movements and speech. The app’s AI recognizes facial muscle movements that are associated with pain and combines this with the carer’s observations to calculate an overall pain score.
According to the company, PainChek can detect pain with over 90% accuracy and more than 180,000 pain assessments have been completed worldwide on over 66,000 people. The app was designed for use with elderly people needing care.
A team of scientists from the school of pharmacy at Curtin University in Western Australia started developing PainChek in 2012. They wanted to find a better alternative to subjective paper-based assessments.
“It’s very difficult for humans to decode the emotions of the person’s face,” explains Peter Shergill, PainChek’s business development director. “So the tool applies artificial intelligence and algorithms to decode the face based on decades of research.”
“Globally, the assessment of pain in people living with dementia is not strong,” says Shergill. “Where pain goes undetected or untreated in people living with dementia, it can manifest in difficult-to-control behaviors, which subsequently people try to control with antipsychotic medication, which brings further risks.”
In 2019, the Australian government allocated up to 5 million Australian dollars ($3.8 million) for care homes in the country to adopt PainChek as part of a two-year trial. “It aims to improve the diagnosis and management of pain, quality of life and health outcomes for people living in residential care,” says Richard Colbeck, the Federal Minister for Senior Australians and Aged Care Services.
PainChek says its technology is currently being used in over 722 care homes globally. Last August, it launched in the United Kingdom, where it has been used by around 1,000 patients so far.
Paul Rowley owns a 24-bed residential home in the United Kingdom and has been using PainChek for almost a year. He says 20 of his residents have diagnosed dementia.
“[People with dementia] have difficulty communicating and they can’t necessarily articulate what they are feeling, so that often leaves the carer having to interpret their feelings,” says Rowley. He says the app is helping carers quickly determine whether somebody is in pain.
For Rowley, PainChek is also an important tool to show the absence of pain. He gives an example where he and his staff were able to use the app to prevent a woman from being unnecessarily medicated.
“We have one lady who is very advanced in her dementia and was manifesting signs that would be interpreted by most people as physical pain,” he says. “But we knew the lady very well and were convinced that in fact what she was manifesting was not pain but frustration and anxiety, and we used PainChek to demonstrate that.”
PainChek is also looking to develop products targeting other groups. It has been carrying out research at a pediatric hospital in Melbourne to help develop an app to identify pain in children under three.
“We are looking at learning disability, delirium and end of life, as well as further additions,” Shergill says. “We have a unique solution that is transferable across ethnicities and backgrounds … users can see the impact they are having.”